# Upfront Surgery Versus NeoAdjuvant Chemotherapy Followed by Surgery for Resectable Advanced Gastric Cancer: SNAC Study

> **NCT06472063** · — · RECRUITING · sponsor: **San Luigi Gonzaga Hospital** · enrollment: 684 (estimated)

## Conditions studied

- Gastric Cancer

## Interventions

- **OTHER:** pre- or perioperative treatment and D2 gastrectomy

## Key facts

- **NCT ID:** NCT06472063
- **Lead sponsor:** San Luigi Gonzaga Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-09-22
- **Primary completion:** 2023-08-30
- **Final completion:** 2024-09-30
- **Target enrollment:** 684 (ESTIMATED)
- **Last updated:** 2024-06-24

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06472063

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06472063, "Upfront Surgery Versus NeoAdjuvant Chemotherapy Followed by Surgery for Resectable Advanced Gastric Cancer: SNAC Study". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT06472063. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*